You are here: Industry Insights > FDA

News List

Lilly's Pain Clinical Trial Protocol Selected for FDA Trial Designs Pilot Meeting Program americanpharmaceuticalreview
September 09, 2019
Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) has accepted its application to enter the Complex Innovative Trial Designs (CID) Pilot Meeting Program...
Cantargia Submits Request for pre-IND Meeting on CAN04 with FDA americanpharmaceuticalreview
September 09, 2019
Cantargia announced a request for a pre-IND meeting with the US FDA has been submitted.
Novadoz/MSN Labs Receives FDA Clearance for Fosaprepitant, Decitabine americanpharmaceuticalreview
September 09, 2019
Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India...
Fosaprepitant and Decitabine generics receive FDA approval europeanpharmaceuticalreview
September 09, 2019
Generic treatments for blood/bone marrow disorders and acute nausea and vomiting associated with chemotherapy have gained FDA approval.
FDA Approves Ofev (nintedanib) for Interstitial Lung Disease Associated with Systemic Sclerosis or Scleroderma (SSc-ILD) drugs
September 09, 2019
The U.S. Food and Drug Administration today approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated...
In the race for permanent FDA chief, Sharpless is a top pick. But he's not alone fiercepharma
September 08, 2019
Whom will the Trump administration nominate for the top FDA job? Acting Commissioner Ned Sharpless is one contender—and he reportedly scored endorsements from five former FDA chiefs, not to mention a laundry list of patient groups. But he’s not the only c
AmEx Pharmacy Issues Voluntary Nationwide Recall for all Lots of Bevacizumab americanpharmaceuticalreview
September 05, 2019
AmEx Pharmacy has announces a voluntary recall of all Lots of Bevacizumab 1.25mg/0.05mL 31G Injectable and all Lots of Bevacizumab 2.5mg/0.1ml Normject TB Injectable...
Kyowa Kirin gets FDA nod for Parkinson’s drug biospectrumasia
September 04, 2019
Kyowa Kirin Announces FDA Approval of NOURIANZTM (istradefylline) for Use in Parkinson’s Disease
US FDA fast tracks Inotrem’s nangibotide for septic shock pharmaceutical-technology
September 04, 2019
The US Food and Drug Administration (FDA) has awarded fast track designation to French biotechnology firm Inotrem’s nangibotide programme, which is being developed to treat septic shock.
FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannula drugs
September 04, 2019
Allergan plc announced today it received U.S. Food and Drug Administration (FDA) approval for the use of Juvéderm Voluma XC...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 366 367 Next page